1. Accurate and efficient non-invasive strategy for early identification of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism (InShape II study). (25th November 2020) Authors: Klok, E; Boon, G.J.A.M; Ende-Verhaar, Y.M; Bavalia, R; Delcroix, M; Dzikowska-Diduch, O; Kurnicka, K; Mairuhu, A.T.A; Middeldorp, S; Pruszczyk, P; Ruigrol, D; Verhamme, P; Vliegen, H; Vonk Noordegraaf, A; Huisman, M.V Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acquired von Willebrand Syndrome in left Impella supported cardiogenic shock patients. (25th November 2020) Authors: Vandenbriele, C; Balthazar, T; Engelen, M; Adriaenssens, T; Verhamme, P; Peerlinck, K; Janssens, S; Jacquemin, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association of fatal and non-fatal adverse health outcomes with urinary peptides reflecting collagen I turnover. (3rd October 2022) Authors: Melgarejo, J; Wei, D; Latosinska, A; Vanassche, T; Janssens, S; Mischak, H; Staessen, J A; Verhamme, P; Zhang, Z Y Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Atherogenic lipoprotein profile associated with anthropometric indices of obesity and their association with cardiometabolic risk markers: a cross-sectional study in community. (3rd October 2022) Authors: Wei, D; Melgarejo, J; Vanassche, T; Van Aelst, L; Janssens, S; Verhamme, P; Redon, J; Zhang, Z Y Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CHA2DS2-VASc and CHADS2 scores for risk stratification of major adverse cardiovascular events in the COMPASS trial. (25th November 2020) Authors: Sen, J; Tonkin, A; Varigos, J; Fonguh, S; Berkowitz, S.D; Yusuf, S; Verhamme, P; Vanassche, T; Anand, S; Fox, K.A.A; Eikelboom, J.W; Amerena, J Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of low-dose rivaroxaban on top of aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial. (25th November 2020) Authors: Vanassche, T; Verhamme, P; Leong, D; Bhatt, D.L; Shestakovska, O; Maggioni, A.P; Fox, K.A.A; Muehlhofer, E; Connolly, S; Yusuf, S; Eikelboom, J; Bosch, J Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Heparin is more effective than apixaban in inhibiting in vitro contact activated coagulation. (25th November 2020) Authors: Engelen, M.M; Van Laer, C; Jacquemin, M; Vandenbriele, C; Peerlinck, K; Verhamme, P; Vanassche, T Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. INITIAL RESULTS OF THE RE-VERSE AD TRIAL: IDARUCIZUMAB REVERSES THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY OR INTERVENTIONS. Issue 12 (23rd November 2015) Authors: Pollack, C; Eikelboom, J; Weitz, J; Reilly, P; Glund, S; Dubiel, R; Kreuzer, J; Stangier, J; Wang, B; Gagg, J; Verhamme, P; Bernstein, R; Huisman, M; Hylek, E; Kamphuisen, P; Levy, J; Selke, F; Steiner, T; Kam, C Journal: Emergency medicine journal Issue: Volume 32:Issue 12(2015) Page Start: 979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Optimal antithrombotic regimen in patients with cardiogenic shock on ImpellaTM mechanical support: less might be more. (25th November 2020) Authors: Vandenbriele, C; Dannenberg, L; Monteagudo-Vela, M; Balthazar, T; Metzen, D; Voss, F; Horn, P; Westenfeld, R; Zeus, T; Kelm, M; Verhamme, P; Janssens, S; Panoulas, V; Price, S; Polzin, A Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Repolarization abnormalities at admission predict 30-day outcome in COVID-19. (24th May 2021) Authors: Vandenberk, B; Van De Sijpe, G; Ingelaere, S; Engelene, M; Vermeulen, J; Verhamme, P; De Munter, P; Lorent, N; Willems, R Journal: Europace Issue: Volume 23:Supplement 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗